| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |